Stockhead on MSN9m
In big news week Neurizon secures key orphan status for motor neurone drug in EuropeEuropean Medicines Agency grants orphan drug designation for Neurizon’s lead drug candidate NUZ-001 to treat Amyotrophic ...
Hosted on MSN40m
Health Check: Joy as Mesoblast wins its first FDA approval for a stem-cell therapy after decades of tryingAfter years of trying, Mesoblast has won US FDA approval for its stem-cell therapies to treat the fatal graft-versus-host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback